Forty percent of New Zealanders are paying more in their power bills because of the phase-out of low-user tariffs, according to a new report. The low-user tariff scheme was designed to encourage lower ...

The second phase of Mumbai Metro Line 3, also known as the Aqua Line, is nearing its launch. The Commissioner of Metro Rail Safety (CMRS) began inspecting the 9.77-km underground stretch from Bandra ...

Kenya Power has secured Sh12 billion from the African Development Bank (AfDB) to finance the third phase of the Last Mile ... cash to fund the construction of three 33/11kV (kilovolts) new ...

It was also the fastest-growing power source for the 20th year in a row. In just three years, global solar power generation doubled to 6.9% of the electricity mix. India, too, saw a rapid increase ...

The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase and three-phase applications, providing superior flexibility to ...

Opposition Leader Peter Dutton will promise Australians a 3 per cent cut in household energy ... Anthony Albanese for failing to bring down power bills by $275 as promised, the opposition has ...

378 batting average with three home runs and 10 RBIs through only 10 games. The sky might be the limit for Merrill as he looks to climb the power rankings this season. Like Vladimir Guerrero Jr ...

Although we are only entering the third week of the 2025 season, some teams are beginning to separate themselves in the MLB power rankings ... was able to combine his three favorite things ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

On April 4, the U.S. Space Force selected SpaceX, ULA and Blue Origin to provide launch services under its NSSL Phase 3 Lane 2 program, worth a cumulative $13.7 billion. SpaceX received the lion ...

Guselkumab, an IL-23 inhibitor, is effective in reducing signs, symptoms, and structural damage in active PsA, as confirmed by the APEX study. The FDA approved guselkumab in 2020 based on DISCOVER ...